Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK

Masakazu Kono; Koichiro Tatsumi; Alberto M Imai; Kengo Saito; Takayuki Kuriyama; Hiroshi Shirasawa

doi:10.1016/j.antiviral.2007.10.011

Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK

Antiviral Res. 2008 Feb;77(2):150-2. doi: 10.1016/j.antiviral.2007.10.011. Epub 2007 Nov 20.

Authors

Masakazu Kono¹, Koichiro Tatsumi, Alberto M Imai, Kengo Saito, Takayuki Kuriyama, Hiroshi Shirasawa

Affiliation

¹ Department of Molecular Virology, Chiba University School of Medicine, 1-8-1 Inohana, Chiba 260-8670, Japan.

Abstract

The antiviral effects of chloroquine (CQ) on human coronavirus 229E (HCoV-229E) infection of human fetal lung cell line, L132 are reported. CQ significantly decreased the viral replication at concentrations lower than in clinical usage. We demonstrated that CQ affects the activation of p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK). Furthermore, p38 MAPK inhibitor, SB203580, inhibits CPE induced by HCoV-229E infection and viral replication. Our findings suggest that CQ affects the activation of MAPKs, involved in the replication of HCoV-229E.

MeSH terms

Antiviral Agents / pharmacology*
Cell Line
Chloroquine / pharmacology*
Coronavirus 229E, Human / drug effects*
Cytopathogenic Effect, Viral / drug effects
Epithelial Cells / virology*
Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors*
Humans
Imidazoles / pharmacology
Lung / cytology
Lung / virology*
Pyridines / pharmacology
Reverse Transcriptase Polymerase Chain Reaction
Virus Replication / drug effects
p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors*

Substances

Antiviral Agents
Imidazoles
Pyridines
Chloroquine
Extracellular Signal-Regulated MAP Kinases
p38 Mitogen-Activated Protein Kinases
SB 203580